BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15980976)

  • 21. Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma.
    Zhang Z; Wang Z; Sun L; Li X; Huang Q; Yang T; Wu H
    Genet Med; 2014 Mar; 16(3):264-70. PubMed ID: 24030433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of mutations in the SCH gene in schwannomas.
    Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
    Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative genomic hybridization and mutation analyses of sporadic schwannomas.
    Ikeda T; Hashimoto S; Fukushige S; Ohmori H; Horii A
    J Neurooncol; 2005 May; 72(3):225-30. PubMed ID: 15937644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants.
    Carlson ML; Smadbeck JB; Link MJ; Klee EW; Vasmatzis G; Schimmenti LA
    Otol Neurotol; 2018 Oct; 39(9):e860-e871. PubMed ID: 30106846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
    Koutsimpelas D; Ruerup G; Mann WJ; Brieger J
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):33-7. PubMed ID: 22249120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.
    Lee JD; Kwon TJ; Kim UK; Lee WS
    PLoS One; 2012; 7(1):e30418. PubMed ID: 22295085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
    Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
    Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
    Halum SL; Erbe CB; Friedland DR; Wackym PA
    Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
    Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
    J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis and molecular pathology of vestibular schwannoma].
    Brodhun M; Stahn V; Harder A
    HNO; 2017 May; 65(5):362-372. PubMed ID: 27421984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
    Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
    J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
    Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
    J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.